e-learning
resources
Milan 2017
Sunday, 10.09.2017
Systemic and airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Could Monocyte /HDL cholesterol ratio predict cardiovascular events in patients with Chronic Obstructive Pulmonary Disease ?
H. Yakar (Istanbul, Turkey)
Source:
International Congress 2017 – Systemic and airway biomarkers
Session:
Systemic and airway biomarkers
Session type:
Thematic Poster
Number:
1007
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Yakar (Istanbul, Turkey). Could Monocyte /HDL cholesterol ratio predict cardiovascular events in patients with Chronic Obstructive Pulmonary Disease ?. 1007
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Endoscopy
Related content which might interest you:
Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019
Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Impact of non-alcoholic fatty liver disease on late cardiovascular events and death in Chronic Obstructive Pulmonary Disease
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Association of serum uric acid levels and outcomes of patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Association between estimated Glomerular Filtration Rate (eGFR) and cardiovascular risk in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017
Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009
Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020
Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020
Predictive factors for readmission of patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Pharmacological treatment of stable Chronic Obstructive Pulmonary Disease: Where do we stand?
Source: International Congress 2018 – COPD management
Year: 2018
Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020
The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept